120
Participants
Start Date
March 16, 2023
Primary Completion Date
April 7, 2026
Study Completion Date
October 7, 2029
Frespaciguat
Frespaciguat 380 µg administered as dry powder inhalation once daily.
Placebo
Placebo administered as dry powder inhalation once daily.
Université Libre de Bruxelles - Hôpital Erasme ( Site 1302), Brussels
Centro Medico Capital ( Site 0301), La Plata
Royal Prince Alfred Hospital-Department of Respiratory Medicine ( Site 0903), Camperdown
Westmead Hospital ( Site 0902), Westmead
Charlotte Maxeke Johannesburg Academic Hospital ( Site 2108), Johannesburg
Netcare Milpark Hospital ( Site 2103), Johannesburg
UZ Leuven ( Site 1301), Leuven
Instituto de Cardiologia de Tucuman-Area de Investigacion Clinica ( Site 0303), San Miguel de Tucumán
Netcare St Augustine's Hospital ( Site 2105), Durban
University Hospital Basel ( Site 2205), Basel
The Prince Charles Hospital ( Site 0904), Brisbane
WESLEY RESEARCH INSTITUTE Limited ( Site 0906), Auchenflower
Mater Misericordiae Limited ( Site 0905), South Brisbane
Medizinische Universitaet Innsbruck ( Site 1202), Innsbruck
TREAD Research ( Site 2101), Cape Town
Medizinische Universität Graz-Klinische Abteilung für Pulmonologie ( Site 1201), Graz
UniversitätsSpital Zürich ( Site 2201), Zurich
Cantonal Hospital St.Gallen ( Site 2203), Sankt Gallen
C.H.U Hôpital Nord ( Site 1503), Marseille
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0704), Mexico City
Instituto Nacional de Cardiologia Ignacio Chavez ( Site 0701), México
Unidad de Investigacon de la Clinica Internacional ( Site 0804), Lima Cercado
Clinica Ricardo Palma-Centro de Investigacion de Enfermedades Respiratorias Thorax ( Site 0806), San Isidro
Clínica Providencia ( Site 0803), San Miguel
UPMC Montefiore University Hospital-Department of Medicine ( Site 0149), Pittsburgh
Temple University Hospital ( Site 0104), Philadelphia
Ospedale San Gerardo-ASST Monza-Cardio Vasolare- Clinica pneumologica ( Site 1802), Monza
Gachon University Gil Medical Center ( Site 1101), Namdong-gu
University of Virginia Health System-Division of Pulmonary and Critical Care Medicine ( Site 0111), Charlottesville
Universitätsklinikum Schleswig-Holstein-Pneumologie ( Site 1605), Lübeck
Eskisehir Osmangazi University-Cardiology ( Site 2304), Eskişehir
UNC Health - Eastowne Medical Office-Clinical Trials Unit ( Site 0147), Chapel Hill
Medizinische Hochschule Hannover ( Site 1602), Hanover
Clinovation Intl. Corp. ( Site 0108), Sebring
Istanbul Universitesi Istanbul Tıp Fakultesi Hastanesi-Chest Disease ( Site 2302), Istanbul
Cattinara Hospital ( Site 1801), Trieste
UKGM Gießen/Marburg ( Site 1604), Giessen
Hospital Universitario Marqués de Valdecilla-Pneumology ( Site 2003), Santander
Lexington VA Medical Center - Cooper Division ( Site 0137), Lexington
HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO ( Site 2005), Seville
Corewell Health ( Site 0133), Grand Rapids
CHU Angers ( Site 1506), Angers
University of Iowa ( Site 0103), Iowa City
INVECORDIS S.C. ( Site 0703), Hacienda de Las Palmas
Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois ( Site 1502), Vandœuvre-lès-Nancy
Mayo Clinic in Rochester, Minnesota ( Site 0131), Rochester
Alexian Brothers Medical Center-Pulmonary ( Site 0109), Elk Grove Village
University of Kansas Medical Center-IM-Pulmonary and Critical Care Medicine ( Site 0102), Kansas City
Creighton University Clinical Research Office ( Site 0123), Omaha
Thoraxklinik-Heidelberg gGmbH-Zentrum für Pulmonale Hypertonie ( Site 1603), Heidelberg
UT Southwestern Medical Center ( Site 0114), Dallas
The University of Texas Health Science Center at Houston ( Site 0105), Houston
University of Colorado Anschutz Medical Campus-University of Colorado Hospital Cardiac and Vascular ( Site 0101), Aurora
Intermountain Medical Center-Division of Pulmonary & Critical Care Medicine ( Site 0140), Murray
Centre Hospitalier Universitaire de Poitiers ( Site 1505), Poitiers
University of New Mexico Hospital ( Site 0146), Albuquerque
ISMETT Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione ( Site 1804), Palermo
UCSF Helen Diller Medical Center at Parnassus Heights ( Site 0110), San Francisco
Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre-Pneumologie ( Site 1501), Le Kremlin-Bicêtre
Fundación Valle del Lili ( Site 0509), Santiago de Cali
Centro de Investigaciones Clinicas SAS ( Site 0505), Santiago de Cali
Rambam Health Care Campus ( Site 1701), Haifa
Fundación Respirar ( Site 0305), CABA
Hospital Britanico de Buenos Aires ( Site 0307), CABA
Hospital Privado Universitario de Córdoba-Clinical Cardiology Department ( Site 0302), Córdoba
Clinica Cardio VID ( Site 0504), Medellín
Ciensalud Ips S A S ( Site 0508), Barranquilla
Universitaetsklinikum Carl Gustav Carus Dresden ( Site 1601), Dresden
Unidad De Diagnostico Cardiologico-Unidad de Diagnostico Cardiologico ( Site 0605), Guatemala City
MEDI-K ( Site 0607), Guatemala City
Clinica Medica ( Site 0601), Guatemala City
Private Practice - Dr. Jeremias Guerra Mejia ( Site 0603), Guatemala City
Rabin Medical Center ( Site 1702), Petah Tikva
Centro Médico Nacional Siglo XXI ( Site 0708), Mexico City
Seoul National University Hospital ( Site 1103), Seoul
Asan Medical Center ( Site 1102), Seoul
Samsung Medical Center ( Site 1104), Seoul
HOSPITAL CLÍNIC DE BARCELONA ( Site 2001), Barcelona
Parc de Salut Mar - Hospital del Mar ( Site 2006), Barcelona
Hospital Universitari Vall d'Hebron ( Site 2002), Barcelona
Hacettepe Universite Hastaneleri ( Site 2301), Ankara
Ankara Bilkent Şehir Hastanesi. ( Site 2307), Ankara
Hammersmith Hospital-Department of Cardiology ( Site 2401), London
Sheffield Teaching Hospitals NHS Foundation Trust-Clinical Research Facility ( Site 2405), Sheffield
Merck Sharp & Dohme LLC
INDUSTRY